An increase in women percentage converting to Phexxi from Hormonal Birth control bodes well for Evofem Biosciences Inc (NASDAQ: EVFM). In contrast, Braemar Hotels & Resorts (NYSE: BHR) declared a preferred dividend for 3Q 2021.
Higher volume to support growth: Evofem Biosciences Inc (NASDAQ: EVFM) released preliminary data sets for Phexxi for the second quarter of 2021. The data release shows the strong conversion of women to Phexxi from Hormonal Birth control. The company sold over 14,000 Phexxi units in the 2Q 2021. Moreover, nearly 5,400 healthcare provides prescribed Phexxi, thereby taking the total count to 7,000 since the launch date. As per the data, of the women using Phexxi, 60% are between 18-34 years of age. The company indicates that looking at the data, it seems the movement is happening quickly. In addition, they also stated that since women are now also concerned with a healthy lifestyle, Phexxi is a natural fit as it hormone-free contraceptive. The company would further share the details during the conference call scheduled in August.
Announced dividend: Braemar Hotels & Resorts (NYSE: BHR) a real estate investment trust, stated that the company announced a cash dividend for the third quarter ending September 30, 2021. As per the release, a quarterly cash dividend of $0.3438 per share for a 5.50% Series B CCPS (Cumulative Convertible Preferred Stock), payable on October 15, 20201. A quarterly cash dividend of $0.5156 per share for its 8.25% Series D Cumulative Preferred Stock, payable on the same date. Further, the company monthly cash dividend of $0.50 per share for each quarter on its Series E Redeemable Preferred Stock, payable on different dates. Further, the company announced a monthly cash dividend of $0.5125 per share per quarter for Series M Redeemable Preferred Stock. Dividend for its Series E and Series M Redeemable Preferred Stock is payable in the four different tranches. The last tranche will be paid on October 15, 2021.